CLINICAL TRIALS PROFILE FOR HALFLYTELY

All Clinical Trials for halflytely

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00164151 ↗	A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.	Completed	Braintree Laboratories	Phase 3	2001-06-01	The objective of this study is to determine the efficacy and safety of HalfLytely as compared to Visicol as bowel preparations before colonoscopic examination.
NCT00164164 ↗	HalfLytely Bowel Prep System for Colonoscopy	Completed	Braintree Laboratories	Phase 3	1999-08-01	The purpose of the this study was to compare the safety and efficacy of HalfLytely (2L NULYTELY + 20mg bisacodyl) to NULYTELY for preparation prior to colonoscopy.
NCT00164177 ↗	Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.	Completed	Braintree Laboratories	Phase 4	2004-10-01	To evaluate the efficacy of standard HalfLYTELY® as a bowel cleansing preparation for adult patients undergoing virtual colonoscopy (VC).
NCT00278967 ↗	An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects	Completed	Braintree Laboratories	Phase 4	2006-02-01	To compare the safety and efficacy of 2 different bowel cleansing preparations prior to colonoscopy in adult subjects.
NCT01073930 ↗	Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep	Completed	Ferring Pharmaceuticals	Phase 3	2010-05-01	Subjects undergoing an elective complete colonoscopy will randomly receive either PicoPrep: 2-sachets for oral solution in two divided doses given a night before (first dose - sachet) and approximately 5 hours prior to procedure (second dose - sachet) or HalfLytely: for oral solution and two 5 mg Bisacodyl tablets, given the day before the procedure to evaluate its effectiveness, tolerability and safety.
NCT01073943 ↗	Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep	Completed	Ferring Pharmaceuticals	Phase 3	2010-05-01	Subjects undergoing an elective complete colonoscopy will randomly receive either PicoPrep: 2-sachets for oral solution in two divided doses given in the afternoon (first dose - sachet) and 6 hours later in the evening (second dose - sachet), given the day before the procedure or HalfLytely: for oral solution and two 5 mg Bisacodyl tablets, given the day before the procedure to evaluate its effectiveness, tolerability and safety.

Clinical Trial Conditions for halflytely

Condition Name

Condition Name for halflytely
Intervention	Trials
Colonoscopy	4
Bowel Preparation	2
Colon Cleansing	1
Colonic Neoplasms	1

Condition MeSH

Condition MeSH for halflytely
Intervention	Trials
Colonic Neoplasms	1

Clinical Trial Locations for halflytely

Trials by Country

Trials by Country for halflytely
Location	Trials
United States	43

Trials by US State

Trials by US State for halflytely
Location	Trials
North Carolina	4
New York	3
Maryland	3
Louisiana	3
Florida	3

Clinical Trial Progress for halflytely

Clinical Trial Phase

Clinical Trial Phase for halflytely
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	4
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for halflytely
Clinical Trial Phase	Trials
Completed	8

Clinical Trial Sponsors for halflytely

Sponsor Name

Sponsor Name for halflytely
Sponsor	Trials
Braintree Laboratories	4
Ferring Pharmaceuticals	2
Valeant Pharmaceuticals International, Inc.	1

Sponsor Type

Sponsor Type for halflytely
Sponsor	Trials
Industry	8
Other	1